Original Article
The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
N Engl J Med 1999; 340:1449-1454May 13, 1999
- Abstract
Background
In 1996, the Food and Drug Administration issued a regulation requiring all enriched grain products to be fortified with folic acid to reduce the risk of neural-tube defects in newborns. Fortification (140 μg per 100 g) began in 1996, and the process was essentially complete by mid-1997.
Methods
To assess the effect of folic acid fortification on folate status, we measured plasma folate and total homocysteine concentrations (a sensitive marker of folate status) using blood samples from the fifth examination (January 1991 to December 1994) of the Framingham Offspring Study cohort for base-line values and the sixth examination (January 1995 to August 1998) for follow-up values. We divided the cohort into two groups on the basis of the date of their follow-up examination: the study group consisted of 350 subjects who were seen after fortification (September 1997 to March 1998), and the control group consisted of 756 subjects who were seen before fortification (January 1995 to September 1996).
Results
Among the subjects in the study group who did not use vitamin supplements, the mean folate concentrations increased from 4.6 to 10.0 ng per milliliter (11 to 23 nmol per liter) (P<0.001) from the base-line visit to the follow-up visit, and the prevalence of low folate concentrations (<3 ng per milliliter [7 nmol per liter]) decreased from 22.0 to 1.7 percent (P< 0.001). The mean total homocysteine concentration decreased from 10.1 to 9.4 μmol per liter during this period (P<0.001), and the prevalence of high homocysteine concentrations (>13 μmol per liter) decreased from 18.7 to 9.8 percent (P<0.001). In the control group, there were no statistically significant changes in concentrations of folate or homocysteine.
Conclusions
The fortification of enriched grain products with folic acid was associated with a substantial improvement in folate status in a population of middle-aged and older adults.
Media in This Article
Figure 2
Plasma Total Homocysteine Concentrations in the Study Group before and after Folic Acid Fortification, According to the Use of B Vitamin Supplements.Figure 1
Plasma Folate Concentrations in the Study Group before and after Folic Acid Fortification, According to the Use of B Vitamin Supplements.Article Activity
- Article
In 1996, the Food and Drug Administration (FDA) issued a regulation, to be effective by January 1998, requiring that all enriched flour, rice, pasta, cornmeal, and other grain products contain 140 μg of folic acid per 100 g in addition to the thiamine, riboflavin, niacin, and iron already present in such products.1 The goal of this folic acid fortification was to increase the intake of folate by women of childbearing age in response to the recommendation of the Public Health Service that “all women of childbearing age in the United States who are capable of becoming pregnant should consume 0.4 mg of folic acid per day for the purpose of reducing their risk of having a pregnancy affected with spina bifida or other NTDs (neural tube defects).”2 This recommendation followed the release of the results of a randomized, controlled clinical trial that found that vitamin supplements containing folic acid prevented many neural-tube defects.3 This outcome was consistent with the results of other randomized trials,4,5 nonrandomized trials,6,7 and observational studies8-11 of periconceptional folate intake. It was estimated that folic acid fortification at the level of 140 μg per 100 g would provide an additional 80 to 100 μg of folic acid per day to the diet of women of childbearing age and 70 to 120 μg to the diet of middle-aged and older adults.12 Discussion continues regarding the need for a higher level of fortification.13
Data to assess the initial effect of folic acid fortification on plasma folate concentrations are available from a population-based sample of middle-aged and older adults who attended the fifth and sixth examination cycles of the Framingham Offspring Study. The fifth examination was completed before the implementation of fortification and provides data on prefortification folate status for all members of the Framingham Offspring cohort. The sixth examination was started before fortification but continued until after full implementation of fortification, thus providing a group of persons who were exposed to folic acid fortification and a comparable group who were not. We also used the plasma total homocysteine concentration, which is a sensitive functional marker of cellular folate status,14 to assess the effect of fortification.
Methods
Subjects
The Framingham Heart Study, an epidemiologic study of heart disease, was established in Framingham, Massachusetts, between 1948 and 1950 with a cohort of 5209 men and women who were 30 to 59 years of age.15 By 1971, the original cohort included 1644 married couples and 378 individuals in whom cardiovascular disease had developed. The offspring of these subjects and the spouses of the offspring were invited to participate, and 5135 of the 6838 eligible persons participated in the first examination of the Framingham Offspring Study.16 The offspring cohort has subsequently undergone follow-up examinations approximately every three to four years. The fifth examination of the offspring cohort began in January 1991 and was completed in December 1994. The sixth examination began in January 1995 and was completed in August 1998.
Determination of Exposure to Folic Acid Fortification
The final regulation for folic acid fortification of grain products was issued in March 1996, with an effective date of January 1, 1998. The FDA established this two-year period to allow manufacturers to exhaust packaging inventory and to update labels. However, the FDA stated that compliance could begin immediately.1 To our knowledge there was minimal, if any, fortification of foods before September 1996. In New England, most of the targeted products were fortified with folic acid by July 1997 (Watson J, Watson Foods, New Haven, Conn.: personal communication).
The fifth examination of the cohort was completed before fortification began. The sixth examination began before the start of fortification and continued until after fortification was in place. We identified members of the cohort whose sixth examination occurred after targeted foods began to be fortified (September 1997 to March 1998) and designated those subjects as the study group. The availability of prefortification (base-line) data from the fifth examination and postfortification (follow-up) data from the sixth examination allowed us to assess any change in folate status that occurred with fortification in the study group. Members of the cohort whose sixth examination occurred before fortification began (January 1995 to September 1996) constituted the control group, and we used data from the fifth and sixth examinations to estimate time-related changes in folate status unrelated to fortification over a three-year period. We further divided the study and control groups into those who used vitamin supplements containing folic acid and those who did not.
Measurements
As part of the fifth and sixth examinations, blood samples were obtained after the participants had fasted (for >10 hours) to determine the concentrations of homocysteine, folate, vitamin B12, and pyridoxal 5'-phosphate (the active, circulating form of vitamin B6). Analyses of the samples from the fifth examination are complete.
The total homocysteine concentration in plasma was determined by high-performance liquid chromatography with fluorometric detection17; plasma folate was measured by a microbial (Lactobacillus casei) assay in a 96-well plate18,19; plasma pyridoxal 5'-phosphate was measured by the tyrosine decarboxylase apoenzyme method20; and plasma vitamin B12 was measured by a radioimmunoassay (Quantaphase II, Bio-Rad, Hercules, Calif.). Coefficients of variation for these assays were 8 percent for homocysteine, 13 percent for folate, 16 percent for pyridoxal 5'-phosphate, and 7 percent for vitamin B12.
The usual dietary intake of folate was assessed with a food-frequency questionnaire.21 This questionnaire also identified nutrient intake from dietary supplements and from fortified, ready-to-eat breakfast cereals. We included folic acid from fortified cereals with unfortified dietary sources of folate in these analyses, because we wanted to examine the added contribution from the new sources of fortification. The nutrient data base that was used for the questionnaire had not yet been modified to account for the folic acid that had recently been added to foods as part of the fortification program.
Statistical Analysis
We separated the data on subjects who reported use of supplements containing folic acid from the data on those who did not. For this reason it was necessary to exclude 242 subjects who started taking supplements containing folic acid between the fifth and sixth examinations and 95 who stopped taking them during this period.
Because the measurements of plasma homocysteine and folate, and folate intake, were positively skewed, we used log-transformed values. Inverse transformations were used to provide geometric means and their 95 percent confidence intervals. A plasma folate concentration of less than 3 ng per milliliter (7 nmol per liter) was defined as low.22 Because there is no standard definition of a high total homocysteine concentration, we defined it for these analyses as a value of more than 13 μmol per liter, which was the 85th percentile for the cohort at the fifth examination cycle.
We determined the age- and sex-adjusted geometric means and prevalences and their 95 percent confidence intervals for the data from the fifth and sixth examinations. Because the fifth examination was completed before the implementation of fortification, measurements from this examination provided base-line values for both the study and control groups. This allowed us to examine the comparability of the groups before the study group was exposed to fortification. We used follow-up data from the sixth examination to examine the differences between the study group and the control group after the former was exposed to fortification. We used combined data from the fifth and sixth examinations to calculate the changes in folate status in the study group after exposure to fortification and in the control group over a follow-up period of similar length. We compared the base-line and follow-up values between the two groups using the SAS PROC GLM program.23 We also used this program to test for changes between the fifth and sixth examinations within the two groups.
Results
Table 1Table 1
Plasma Folate and Homocysteine Concentrations before and after Folic Acid Fortification in the Framingham Offspring Study Cohort, According to the Use of B Vitamin Supplements. shows the homocysteine and folate concentrations at the base-line (fifth) and follow-up (sixth) examinations for the study and control groups. The plasma folate and homocysteine concentrations at base line were not substantially different between the groups. Pyridoxal 5'-phosphate concentrations were significantly lower among subjects in the study group who did not use B vitamin supplements than among those in the control group who did not use supplements; vitamin B12 concentrations did not differ significantly between the groups (data not shown). Among the subjects in the study group who did not use B vitamin supplements, plasma folate concentrations increased by 117 percent after the introduction of folic acid fortification (P<0.001), the prevalence of low folate concentrations decreased by 92 percent (P<0.001), fasting total homocysteine concentrations decreased by 7 percent (P<0.001), and the prevalence of high homocysteine concentrations decreased by 48 percent (P<0.001) from the base-line to the follow-up examination. Among the subjects in the control group who did not take B vitamin supplements, the only significant change was an increase in reported dietary folate intake (P<0.001).Among subjects in the study and control groups who used B vitamin supplements, we found a significant increase in plasma folate concentrations from the base-line examination to the follow-up examination. Plasma folate concentrations increased by 62 percent in the study group (P<0.001) and by 24 percent in the control group (P<0.001). There was also an 8 percent increase in homocysteine concentrations in the study group (P<0.006).
At the follow-up examination, mean homocysteine concentrations were 10 percent lower among those in the study group who used supplements than among those who did not use supplements (P<0.001), but the prevalence of high homocysteine concentrations was not significantly different between these two subgroups (P=0.62). The difference in mean homocysteine concentrations appears to be largely the result of differences in vitamin B12 and pyridoxal 5'-phosphate status between those who used B vitamin supplements and those who did not. Mean plasma vitamin B12 concentrations were 351 pg per milliliter (259 pmol per liter) in those who did not use supplements and 475 pg per milliliter (350 pmol per liter) in those who did (P<0.001). Similarly, the pyridoxal 5'-phosphate concentrations were 53 nmol per liter in those who did not use supplements and 120 nmol per liter in those who did (P<0.001). After we adjusted for vitamin B12 and pyridoxal 5'-phosphate concentrations, the difference in homocysteine concentrations between those in the study group who used supplements and those who did not was reduced to 6 percent and was no longer statistically significant (P=0.10). In the study group, the prevalence of high homocysteine concentrations was essentially the same for those who used B vitamin supplements and those who did not after adjustment for vitamin B12 and pyridoxal 5'-phosphate concentrations (P=0.83).
Figure 1Figure 1
Plasma Folate Concentrations in the Study Group before and after Folic Acid Fortification, According to the Use of B Vitamin Supplements. and Figure 2Figure 2Plasma Total Homocysteine Concentrations in the Study Group before and after Folic Acid Fortification, According to the Use of B Vitamin Supplements. show the plasma folate and homocysteine concentrations, respectively, at the base-line and follow-up examinations in the study group, according to the use of B vitamin supplements. Figure 1 shows the upward shift in the distribution of plasma folate concentrations from the base-line (prefortification) examination to the follow-up (postfortification) examination for both those who used supplements and those who did not. Figure 2 illustrates the decrease in the area of the upper tail of homocysteine distribution after fortification and the increase in the height of the distribution of normal homocysteine concentrations (<10 μmol per liter) among those who did not use supplements. There was a slight upward shift in homocysteine concentrations between examinations among those who used supplements.Discussion
Our findings suggest that folic acid fortification has had a substantial effect on plasma folate and homocysteine concentrations in a population-based sample of middle-aged and older adults. Low folate concentrations (<3 ng per milliliter) were largely eliminated in this population after folic acid fortification was implemented, and the prevalence of high homocysteine concentrations (>13 μmol per liter) was reduced by approximately 50 percent among those who did not take supplements. The differences in values between those who were exposed to fortification and those who were not exposed appear to be specific for folate. Furthermore, these differences cannot be attributed to changes in folate intake from sources other than folic acid added to the diet as part of fortification.
Although the apparent effect of fortification on plasma folate and homocysteine concentrations was striking, the concentrations of folate were significantly higher, and concentrations of homocysteine significantly lower, among subjects who used vitamin supplements that contained folic acid. The consequences of these differences are not entirely clear. Although the mean folate concentrations among subjects who were exposed to folic acid fortification were higher among those who used supplements than among those who did not, the prevalence of low folate concentrations was very low in both groups and was not significantly different between groups. Among the subjects who were exposed to foods fortified with folic acid, mean homocysteine concentrations were lower in those who used supplements than in those who did not, but this difference did not clearly translate into a difference in the prevalence of high homocysteine concentrations. Approximately 10 percent of those who were not taking supplements had high homocysteine concentrations in the postfortification period, but this prevalence was not significantly different from the approximately 8 percent prevalence of high homocysteine concentrations in those who used supplements.
Moreover, the differences in mean homocysteine concentrations between those who used supplements and those who did not cannot be attributed readily to folate status. There were substantial differences between these two groups in concentrations of vitamin B12 and pyridoxal 5'-phosphate (the active, circulating form of vitamin B6), which are the other important vitamins that determine the concentration of homocysteine. Such a difference can be expected, because all the supplements containing folic acid were either multivitamins or B-complex vitamins that contained vitamins B12 and B6. Thus, any unadjusted comparison of homocysteine concentrations as a measure of folate status between those who used supplements and those who did not is confounded. When we controlled for vitamin B12 and pyridoxal 5'-phosphate concentrations in the analyses, the difference in homocysteine concentrations between those who used supplements and those who did not was reduced substantially and was no longer statistically significant. These data suggest that the higher mean homocysteine concentrations in those who did not use supplements and who were seen during the postfortification period were probably not a consequence of inadequate folate intake. These data provide little evidence that the addition of 400 μg of folic acid per day from supplements to the amount provided by fortification and diet further reduced homocysteine concentrations, but our ability to detect small differences resulting from the additional folic acid is limited by the small number of persons who used supplements and who were exposed to fortification.
It was predicted that folic acid fortification at a level of 140 μg per 100 g would provide an additional 70 to 120 μg of folic acid per day for middle-aged and older adults.12 A recent study examined the effect of three levels of folic acid added to breakfast cereal on plasma total homocysteine and folate concentrations24 and concluded that an additional 100 μg of folic acid per day was not sufficient to minimize total homocysteine concentrations. However, features of that study may limit the applicability of the observation to the general population with long-term exposure to folic acid fortification. The length of treatment was only five weeks, which was probably insufficient to approach a new steady-state concentration at a dose of 100 μg per day,25 and the study was performed in patients with coronary artery disease, who may require a higher folate intake to minimize total homocysteine concentrations.26 The issue of the length of exposure to foods fortified with folic acid was highlighted in a report by Schorah and colleagues.27 They found that folate concentrations in serum and red cells continued to increase and that homocysteine concentrations continued to decrease 8 weeks after the addition of 200 μg of folic acid per day to breakfast cereal, and possibly up to 24 weeks afterward. We must also consider the possibility that enriched grain products are being fortified at levels above the minimum required by the FDA (140 μg per 100 g of cereal or grain product). However, preliminary data on the folic acid content of enriched grain products suggest that this is probably not the case.28 Tests of common national brands of enriched flour, pasta, and rice that are available in the Framingham area revealed that folic acid concentrations ranged from 125 to 136 μg per 100 g in flour, 180 to 205 μg per 100 g in pasta, and 66 to 176 μg per 100 g in rice.
Folic acid fortification was undertaken to reduce the risk of neural-tube defects,1,2 but it may also have a beneficial effect on vascular disease because of the relation between inadequate folate intake and higher circulating homocysteine concentrations.29,30 Elevated fasting total homocysteine concentrations are clearly amenable to treatment with folic acid,31-34 and elevated concentrations of circulating total homocysteine,30,35-39 as well as lower folate intake and status,40-42 are associated with an increased risk of occlusive vascular disease. If a high concentration of homocysteine ultimately proves to be a risk factor for vascular disease, our data indicate that folic acid fortification would have a measurable effect on the rates of cerebrovascular and coronary heart disease in the United States. Only a small proportion of our population was made up of women younger than 40, so we were not able to assess directly the effect of fortification on women of reproductive age. However, we have no reason to believe that the effect of fortification on folate status in women of reproductive age differs from the effect in older adults.
Supported in part by an agreement (58-1950-9-001) with the Department of Agriculture and by a contract (N01-HC-38038) with the National Heart, Lung, and Blood Institute. Any opinions, findings, conclusions, or recommendations expressed in this article are those of the authors and do not necessarily reflect the views of the Department of Agriculture.
Source Information
From the Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston (P.F.J., J.S., I.H.R.); the Division of General Internal Medicine, Memorial Hospital of Rhode Island, Providence (A.G.B.); and the Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham, Mass. (P.W.F.W.).
Address reprint requests to Dr. Rosenberg at the Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, 711 Washington St., Boston, MA 02111.
- References
References
1
Food standards: amendment of standards of identity for enriched grain products to require addition of folic acidFed Regist 1996;61:8781-8797
2
Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defectsMMWR Morb Mortal Wkly Rep 1992;41:1-7
Medline3
MRC Vitamin Study Research Group
CrossRef | Web of Science | Medline4
Czeizel AE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993;306:1645-1648
CrossRef | Web of Science | Medline5
Laurence KM ,James N ,Miller MH ,Tennant GB ,Campbell H . Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 1981;282:1509-1511
CrossRef | Web of Science | Medline6
Vergel RG ,Sanchez LR ,Heredero BL ,Rodriguez PL ,Martinez AJ . Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990;10:149-152
CrossRef | Web of Science | Medline7
Smithells RW ,Nevin NC ,Seller MJ , et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983;1:1027-1031
CrossRef | Web of Science | Medline8
Werler MM ,Shapiro S ,Mitchell AA . Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-1261
CrossRef | Web of Science | Medline9
Mulinare J ,Cordero JF ,Erickson JD ,Berry RJ . Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-3145
CrossRef | Web of Science | Medline10
Milunsky A ,Jick H ,Jick SS , et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-2852
CrossRef | Web of Science | Medline11
Bower C ,Stanley FJ . Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-619
Web of Science | Medline12
Food standards: amendment of the standards of identity for enriched grain products to require addition of folic acidFed Regist 1993;58:53305-53312
13
Oakley GP Jr . Eat right and take a multivitamin. N Engl J Med 1998;338:1060-1061
Full Text | Web of Science | Medline14
Selhub J ,Jacques PF ,Wilson PWF ,Rush D ,Rosenberg IH . Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698
CrossRef | Web of Science | Medline15
Dawber TR ,Moore FE ,Mann GV . Coronary heart disease in the Framingham study. Am J Public Health 1957;47:4-24
CrossRef16
Feinleib M ,Kannel WB ,Garrison RJ ,McNamara PM ,Castelli WP . The Framingham Offspring Study: design and preliminary data. Prev Med 1975;4:518-525
CrossRef | Web of Science | Medline17
Araki A ,Sako Y . Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52
CrossRef | Web of Science | Medline18
Horne DW ,Patterson D . Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates. Clin Chem 1988;34:2357-2359
Web of Science | Medline19
Tamura T ,Freeberg LE ,Cornwell PE . Inhibition by EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron. Clin Chem 1990;36:1993-1993
Web of Science | Medline20
Shin YS ,Rasshofer R ,Friedrich B ,Endres W . Pyridoxal-5'-phosphate determination by a sensitive micromethod in human blood, urine and tissues: its relation to cystathioninuria in neuroblastoma and biliary atresia. Clin Chim Acta 1983;127:77-85
CrossRef | Web of Science | Medline21
Rimm ED ,Giovannucci EL ,Stampfer MJ ,Colditz GA ,Litin LB ,Willett WC . Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-1126
Web of Science | Medline22
Herbert V, Das KC. Folic acid and vitamin B12. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed. Vol. 1. Philadelphia: Lea & Febiger, 1994:402-25.
23
SAS user's guide, version 6. Cary, N.C.: SAS Institute, 1989.
24
Malinow MR ,Duell PB ,Hess DL , et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998;338:1009-1015
Full Text | Web of Science | Medline25
Gregory JF ,Bailey LB ,Toth JP ,Williamson J . Kinetic model of folate metabolism in nonpregnant women chronically given [2H2]folic acid with three levels of total folate intake. FASEB J 1998;12:A511-A511 abstract.
Web of Science26
Hopkins PN ,Wu LL ,Wu J , et al. Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1995;15:1314-1320
CrossRef | Web of Science | Medline27
Schorah CJ ,Devitt H ,Lucock M ,Dowell AC . The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study. Eur J Clin Nutr 1988;52:407-411
CrossRef | Web of Science28
Afman L ,Bagley P ,Selhub J . Determination of folic acid in fortified cereal products using the affinity/HPLC method. FASEB J 1999;13:A891-A891 abstract.
Web of Science29
Tucker KL ,Mahnken B ,Wilson PWF ,Jacques P ,Selhub J . Folic acid fortification of the food supply: potential benefits and risks for the elderly population. JAMA 1996;276:1879-1885[Erratum, JAMA 1997;277:714.]
CrossRef | Web of Science | Medline30
Boushey CJ ,Beresford SA ,Omenn GS ,Motulsky AG . A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057
CrossRef | Web of Science | Medline31
Brattstrom LE ,Israelsson B ,Jeppsson J-O ,Hultberg BL . Folic acid -- an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988;48:215-221
CrossRef | Web of Science | Medline32
Wilcken DEL ,Dudman NPB ,Tyrrell PA ,Robertson MR . Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 1988;37:697-701
CrossRef | Web of Science | Medline33
Landgren F ,Israelsson B ,Lindgren A ,Hultberg B ,Andersson A ,Brattstrom L . Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med 1995;237:381-388
CrossRef | Web of Science | Medline34
Ubbink JB ,Vermaak WJH , van_der_Merwe,Becker PJ ,Delport R ,Potgieter HC . Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124:1927-1933
Web of Science | Medline35
Stampfer MJ ,Malinow MR ,Willett WC , et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-881
CrossRef | Web of Science | Medline36
Arnesen E ,Refsum H ,Bonaa KH ,Ueland PM ,Forde OH ,Nordrehaug JE . Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24:704-709
CrossRef | Web of Science | Medline37
Perry IJ ,Refsum H ,Morris RW ,Ebrahim SB ,Ueland PM ,Shaper AG . Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-1398
CrossRef | Web of Science | Medline38
Graham IM ,Daly LE ,Refsum HM , et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA 1997;277:1775-1781
CrossRef | Web of Science | Medline39
Nygard O ,Nordrehaug JE ,Refsum H ,Ueland PM ,Farstad M ,Vollset SE . Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-236
Full Text | Web of Science | Medline40
Rimm EB ,Willett WC ,Hu FB , et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998;279:359-364
CrossRef | Web of Science | Medline41
Verhoef P ,Stampfer MJ ,Buring JE , et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996;143:845-859
Web of Science | Medline42
Morrison HI ,Schaubel D ,Desmeules M ,Wigle DT . Serum folate and risk of fatal coronary heart disease. JAMA 1996;275:1893-1896
CrossRef | Web of Science | Medline
- Citing Articles (304)
Citing Articles
1
Karrie Kam, Jayashree Arcot, Adesoji A. Adesina. (2012) Folic acid fortification of parboiled rice: Multifactorial analysis and kinetic investigation. Journal of Food Engineering 108:1, 238-243
CrossRef2
K. Leishear, L. Ferrucci, F. Lauretani, R. M. Boudreau, S. A. Studenski, C. Rosano, R. Abbate, A. M. Gori, A. M. Corsi, A. Di Iorio, J. M. Guralnik, S. Bandinelli, A. B. Newman, E. S. Strotmeyer. (2011) Vitamin B12 and Homocysteine Levels and 6-Year Change in Peripheral Nerve Function and Neurological Signs. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
CrossRef3
Mauara Scorsatto, Sofia K. Uehara, Ronir R. Luiz, Gláucia M.M. de Oliveira, Glorimar Rosa. (2011) Fortification of flours with folic acid reduces homocysteine levels in Brazilian women. Nutrition Research 31:12, 889-895
CrossRef4
L. J. Sittig, L. B. K. Herzing, H. Xie, K. K. Batra, P. K. Shukla, E. E. Redei. (2011) Excess folate during adolescence suppresses thyroid function with permanent deficits in motivation and spatial memory. Genes, Brain and Behaviorno-no
CrossRef5
Sheetal Gupta, Crassina A. Shimray, G. Venkateswara Rao. (2011) Influence of organic acids on rheological and bread-making characteristics of fortified wheat flour. International Journal of Food Sciences and Nutrition111109065305002
CrossRef6
Yuya Tamai, Keiko Wada, Michiko Tsuji, Kozue Nakamura, Yukari Sahashi, Kaori Watanabe, Keiko Yamamoto, Kyoko Ando, Chisato Nagata. (2011) Dietary Intake of Vitamin B12 and Folic Acid Is Associated With Lower Blood Pressure in Japanese Preschool Children. American Journal of Hypertension 24:11, 1215-1221
CrossRef7
Anna Floegel, Sang-Jin Chung, Anne von Ruesten, Meng Yang, Chin E Chung, Won O Song, Sung I Koo, Tobias Pischon, Ock K Chun. (2011) Antioxidant intake from diet and supplements and elevated serum C-reactive protein and plasma homocysteine concentrations in US adults: a cross-sectional study. Public Health Nutrition 14:11, 2055-2064
CrossRef8
Joshua Miller. 2011. Homocysteine, B Vitamins, and Cognitive Function. , 189-214.
CrossRef9
Hala Ahmadieh, Asma Arabi. (2011) Vitamins and bone health: beyond calcium and vitamin D. Nutrition Reviews 69:10, 584-598
CrossRef10
Michael Chourdakis, Thrasivoulos Tzellos, Chryssa Pourzitaki, Konstantinos A. Toulis, George Papazisis, Dimitrios Kouvelas. (2011) Evaluation of dietary habits and assessment of cardiovascular disease risk factors among Greek university students. Appetite 57:2, 377-383
CrossRef11
Julia A.M. Anderson, Jeffrey I. Weitz. (2011) Hypercoagulable States. Critical Care Clinics 27:4, 933-952
CrossRef12
Arthur Kummer, Estefânia Harsányi. (2011) Comments on “Vitamin supplementation reduces the level of homocysteine in the urine of autistic children”. Nutrition Research
CrossRef13
Natalia Úbeda, Leticia Reyes, Antonio González-Medina, Elena Alonso-Aperte, Gregorio Varela-Moreiras. (2011) Physiologic changes in homocysteine metabolism in pregnancy: A longitudinal study in Spain. Nutrition 27:9, 925-930
CrossRef14
Katherine Ahrens, Mahsa M. Yazdy, Allen A. Mitchell, Martha M. Werler. (2011) Folic Acid Intake and Spina Bifida in the Era of Dietary Folic Acid Fortification. Epidemiology 22:5, 731-737
CrossRef15
Shilpa N. Bhupathiraju, Katherine L. Tucker. (2011) Coronary heart disease prevention: Nutrients, foods, and dietary patterns. Clinica Chimica Acta 412:17-18, 1493-1514
CrossRef16
Peter Nagele, Konrad Meissner, Amber Francis, Manuela Födinger, Nancy L. Saccone. (2011) Genetic and environmental determinants of plasma total homocysteine levels. Pharmacogenetics and Genomics 21:7, 426-431
CrossRef17
Junya Aoki, Ken Uchino. (2011) Treatment of Risk Factors to Prevent Stroke. Neurotherapeutics 8:3, 463-474
CrossRef18
Jacob Selhub, Ligi Paul. (2011) Folic acid fortification: Why not vitamin B12 also?. BioFactors 37:4, 269-271
CrossRef19
Joel B. Mason. (2011) Unraveling the complex relationship between folate and cancer risk. BioFactors 37:4, 253-260
CrossRef20
Marit P. Martinussen, Kari R. Risnes, Geir W. Jacobsen, Michael B. Bracken. (2011) Folic acid supplementation in early pregnancy and asthma in children aged 6 years. American Journal of Obstetrics and Gynecology
CrossRef21
June Leung, Johanna Dwyer, Patricia Hibberd, Paul Jacques, William Rand, Michael V. Rocco. (2011) Association Between Adherence to Folic Acid Supplements and Serum Folate, and Plasma Homocysteine Among Hemodialysis Patients. Journal of Renal Nutrition 21:3, 246-256
CrossRef22
K. Castetbon, C. Méjean, V. Deschamps, C. Bellin-Lestienne, A. Oleko, N. Darmon, S. Hercberg. (2011) Dietary behaviour and nutritional status in underprivileged people using food aid (ABENA study, 2004-2005). Journal of Human Nutrition and Dieteticsno-no
CrossRef23
Atsuo Kondo, Yoshimasa Asada, Kanemitsu Shibata, Masamichi Kihira, Keiu Ninomiya, Masatoshi Suzuki, Hidenori Oguchi, Yoshihiko Hayashi, Osamu Narita, Junichiro Watanabe, Yoichi Shimosuka. (2011) Dietary folate intakes and effects of folic acid supplementation on folate concentrations among Japanese pregnant women. Journal of Obstetrics and Gynaecology Research 37:4, 331-336
CrossRef24
Yurdanur G. Acılmıs, Ebru Dikensoy, Ali I. Kutlar, Ozcan Balat, Fatma B. Cebesoy, Ebru Ozturk, Hulya Cicek, Sadrettin Pence. (2011) Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre-eclampsia. Journal of Obstetrics and Gynaecology Research 37:1, 45-50
CrossRef25
José Murilo Martins. (2011) Considerations on the food fortification policy in Brazil. Revista Brasileira de Hematologia e Hemoterapia 33:2, 158-163
CrossRef26
Amytis Towfighi, Daniela Markovic, Bruce Ovbiagele. (2011) Persistent Sex Disparity in Midlife Stroke Prevalence in the United States. Cerebrovascular Diseases 31:4, 322-328
CrossRef27
R Green. 2011. Macrocytic anemia. , 197-212.
CrossRef28
Julia A.M. Anderson, Jeffrey I. Weitz. (2010) Hypercoagulable States. Clinics in Chest Medicine 31:4, 659-673
CrossRef29
Amytis Towfighi, Daniela Markovic, Bruce Ovbiagele. (2010) Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: A nationwide study. Journal of the Neurological Sciences 298:1-2, 153-157
CrossRef30
C. A. M. Anderson, S. H. Jee, J. Charleston, M. Narrett, L. J. Appel. (2010) Effects of Folic Acid Supplementation on Serum Folate and Plasma Homocysteine Concentrations in Older Adults: A Dose-Response Trial. American Journal of Epidemiology 172:8, 932-941
CrossRef31
Constantina Papoutsakis, Yannis Manios, Faidon Magkos, Evaggelos Papaconstantinou, Kleopatra H. Schulpis, Antonis Zampelas, Antonia L. Matalas, Nikos Yiannakouris. (2010) Effect of the methylenetetrahydrofolate reductase (MTHFR 677C>T) polymorphism on plasma homocysteine concentrations in healthy children is influenced by consumption of folate-fortified foods. Nutrition 26:10, 969-974
CrossRef32
Carolyn M. Summers, Laura E. Mitchell, Anna Stanislawska-Sachadyn, Shirley F. Baido, Ian A. Blair, Joan M. Von Feldt, Alexander S. Whitehead. (2010) Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women. Birth Defects Research Part A: Clinical and Molecular Teratology 88:8, 679-688
CrossRef33
M G Garrod, L H Allen, M N Haan, R Green, J W Miller. (2010) Transcobalamin C776G genotype modifies the association between vitamin B12 and homocysteine in older Hispanics. European Journal of Clinical Nutrition 64:5, 503-509
CrossRef34
Martina Montagnana, Emmanuel J. Favaloro, Massimo Franchini, Gian Cesare Guidi, Giuseppe Lippi. (2010) The role of ethnicity, age and gender in venous thromboembolism. Journal of Thrombosis and Thrombolysis 29:4, 489-496
CrossRef35
W. Mei, Y. Rong, L. Jinming, L. Yongjun, Z. Hui. (2010) Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials. International Journal of Clinical Practice 64:2, 208-215
CrossRef36
Loic Desquilbet, François Mariotti. (2010) Dose-response analyses using restricted cubic spline functions in public health research. Statistics in Medicinen/a-n/a
CrossRef37
Tao Huang, Mark L. Wahlqvist, Duo Li. (2010) Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism. Nutrition 26:1, 112-119
CrossRef38
Robert Berry, Joseph Mulinare, Heather Hamner. 2009. Folic Acid Fortification. , 179-204.
CrossRef39
Sari Kalin, Eric Rimm. 2009. Folate and Vascular Disease. , 263-290.
CrossRef40
Luciana Hannibal, Alla Glushchenko, Donald Jacobsen. 2009. Folate and Vascular Disease. , 291-323.
CrossRef41
Arturo J Martí-Carvajal, Ivan Solà, Dimitrios Lathyris, Georgia Salanti, Arturo J Martí-Carvajal. 2009. Homocysteine lowering interventions for preventing cardiovascular events. .
CrossRef42
Kim TB Knoops, Avron Spiro, Lisette CPGM de Groot, Daan Kromhout, Wija A van Staveren, Katherine L Tucker. (2009) Do dietary patterns in older men influence change in homocysteine through folate fortification? The Normative Aging Study. Public Health Nutrition 12:10, 1760
CrossRef43
Theresa A. Zesiewicz, Marian L. Evatt. (2009) Potential Influences of Complementary Therapy on Motor and Non-Motor Complications in Parkinsonʼs Disease. CNS Drugs 23:10, 817-835
CrossRef44
Michela Tomaiuolo, Gennaro Vecchione, Maurizio Margaglione, Daniela Pisanelli, Elvira Grandone. (2009) Stable-isotope dilution LC–ESI-MS/MS techniques for the quantification of total homocysteine in human plasma. Journal of Chromatography B 877:28, 3292-3299
CrossRef45
Katia Castetbon, Michel Vernay, Aurélie Malon, Benoit Salanave, Valérie Deschamps, Candice Roudier, Amivi Oleko, Emmanuelle Szego, Serge Hercberg. (2009) Dietary intake, physical activity and nutritional status in adults: the French nutrition and health survey (ENNS, 2006–2007). British Journal of Nutrition 102:05, 733
CrossRef46
Laura E. Mitchell, Megan Morales, Stefanie Khartulyari, Yuehua Huang, Kristen Murphy, Minghua Mei, Joan M. Von Feldt, Ian A. Blair, Alexander S. Whitehead. (2009) Folate and homocysteine phenotypes: Comparative findings using research and clinical laboratory data. Clinical Biochemistry 42:12, 1275-1281
CrossRef47
Arturo J Martí-Carvajal, Andrés Felipe Cardona, Able Lawrence, Arturo J Martí-Carvajal. 2009. Interventions for previously untreated patients with AIDS-associated Non-Hodgkin´s Lymphoma. .
CrossRef48
Farzad Shidfar, Reza Homayounfar, Seyed-Mohammad Fereshtehnejad, Alireza Kalani. (2009) Effect of Folate Supplementation on Serum Homocysteine and Plasma Total Antioxidant Capacity in Hypercholesterolemic Adults under Lovastatin Treatment: A Double-blind Randomized Controlled Clinical Trial. Archives of Medical Research 40:5, 380-386
CrossRef49
A. A. Boldyrev. (2009) Molecular mechanisms of homocysteine toxicity. Biochemistry (Moscow) 74:6, 589-598
CrossRef50
A. Sánchez-Villegas, J. Doreste, J. Schlatter, J. Pla, M. Bes-Rastrollo, M. A. Martínez-González. (2009) Association between folate, vitamin B 6 and vitamin B 12 intake and depression in the SUN cohort study. Journal of Human Nutrition and Dietetics 22:2, 122-133
CrossRef51
Joel B Mason. (2009) Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutrition Reviews 67:4, 206-212
CrossRef52
Liang Liu, Thomas van Groen, Inga Kadish, Trygve O. Tollefsbol. (2009) DNA methylation impacts on learning and memory in aging. Neurobiology of Aging 30:4, 549-560
CrossRef53
Godfrey P. Oakley. (2009) The Scientific Basis for Eliminating Folic Acid–Preventable Spina Bifida: A Modern Miracle from Epidemiology. Annals of Epidemiology 19:4, 226-230
CrossRef54
Michael E. Symonds. (2009) Nutrition and its contribution to obesity and diabetes: a life-course approach to disease prevention?. Proceedings of the Nutrition Society 68:01, 71
CrossRef55
Bradley A. Maron, Joseph Loscalzo. (2009) The Treatment of Hyperhomocysteinemia. Annual Review of Medicine 60:1, 39-54
CrossRef56
S. Hengstermann, G. Laemmler, A. Hanemann, A. Schweter, E. Steinhagen-Thiessen, A. Lun, R. -J. Schulz. (2009) Total serum homocysteine levels do not identify cognitive dysfunction in multimorbid elderly patients. The Journal of Nutrition, Health and Aging 13:2, 121-126
CrossRef57
M. Shargorodsky, M. Boaz, S. Pasternak, R. Hanah, Z. Matas, A. Fux, Y. Beigel, M. Mashavi. (2009) Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?. Diabetes/Metabolism Research and Reviews 25:1, 70-75
CrossRef58
Andrie Panayiotou, Andrew Nicolaides, Maura Griffin, Theodosis Tyllis, Niki Georgiou, Richard M Martin, Dawn Bond, Chrysa Tziakouri-Shiakalli, Charis Fessas, Constantinos Deltas. (2009) Serum total homocysteine, folate, 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C→T genotype and subclinical atherosclerosis. Expert Opinion on Therapeutic Targets 13:1, 1-11
CrossRef59
Atsuo Kondo, Osamu Kamihira, Hideo Ozawa. (2009) Neural tube defects: Prevalence, etiology and prevention. International Journal of Urology 16:1, 49-57
CrossRef60
Leane Hoey, Helene McNulty, Elizabeth M. E. McCann, Kelvin J. McCracken, John M. Scott, Barbara Blaznik Marc, Anne M. Molloy, Ciaren Graham, Kristina Pentieva. (2009) Laying hens can convert high doses of folic acid added to the feed into natural folates in eggs providing a novel source of food folate. British Journal of Nutrition 101:02, 206
CrossRef61
Mi-Ri Hwang, Ju-Ryoun Soh, Hyeon-Sook Lim. (2009) Effects of Folic Acid and Ascorbate Supplementation on Plasma Homocysteine and Oxidative Stress in Patients with Type 2 Diabetes Mellitus. The Korean Journal of Nutrition 42:2, 107
CrossRef62
Julia Sauer, Joel B Mason, Sang-Woon Choi. (2009) Too much folate: a risk factor for cancer and cardiovascular disease?. Current Opinion in Clinical Nutrition and Metabolic Care 12:1, 30-36
CrossRef63
Rongbao Zhao, Larry H. Matherly, I. David Goldman. (2009) Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Expert Reviews in Molecular Medicine 11,
CrossRef64
Hisanori MINAKAMI. (2009) Increased Folate Intake is Recommended. Japanese Journal of Complementary and Alternative Medicine 6:2, 53-57
CrossRef65
Teruhiko Koike, Masafumi Kuzuya, Shigeru Kanda, Kiwako Okada, Sachiko Izawa, Hiromi Enoki, Akihisa Iguchi. (2008) Raised homocysteine and low folate and vitamin B-12 concentrations predict cognitive decline in community-dwelling older Japanese adults. Clinical Nutrition 27:6, 865-871
CrossRef66
D Stettin, A Waldmann, A Ströhle, A Hahn. (2008) Association between <i>Helicobacter pylori</i>-infection, C-reactive protein and status of B vitamins. Advances in Medical Sciences 53:2, 205-213
CrossRef67
L. L. Humphrey, R. Fu, K. Rogers, M. Freeman, M. Helfand. (2008) Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis. Mayo Clinic Proceedings 83:11, 1203-1212
CrossRef68
Reem Malouf, John Grimley Evans, Reem Malouf. 2008. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. .
CrossRef69
Ruth Gil, Jesús Esteban, Valentín Hernández, Beatriz Cano, Manuel de Oya, Ángel Gil. (2008) Folato sérico en población adolescente de la Comunidad de Madrid. Medicina Clínica 131:14, 530-535
CrossRef70
J.B. Richards, A.M. Valdes, J.P. Gardner, B.S. Kato, A. Siva, M. Kimura, X. Lu, M.J. Brown, A. Aviv, T.D. Spector. (2008) Homocysteine levels and leukocyte telomere length. Atherosclerosis 200:2, 271-277
CrossRef71
Elisabetta Trabetti. (2008) Homocysteine,MTHFR gene polymorphisms, and cardio-cerebrovascular risk. Journal of Applied Genetics 49:3, 267-282
CrossRef72
Joshua W Miller, Alexander D Borowsky, Teresa C Marple, Erik T McGoldrick, Lisa Dillard-Telm, Lawrence JT Young, Ralph Green. (2008) Folate, DNA methylation, and mouse models of breast tumorigenesis. Nutrition Reviews 66, S59-S64
CrossRef73
Benjamin Bar-Oz, Gideon Koren, Patricia Nguyen, Bhushan M. Kapur. (2008) Folate fortification and supplementation—Are we there yet?. Reproductive Toxicology 25:4, 408-412
CrossRef74
S. Hengstermann, G. Laemmler, A. Hanemann, A. Schweter, E. Steinhagen-Thiessen, A. Lun, R. -J. Schulz. (2008) Total serum homocysteine levels do not identify cognitive dysfunction in multimorbid elderly patients. The Journal of Nutrition Health and Aging 12:6, 411-416
CrossRef75
Peter D. Cole, Richard A. Drachtman, Margaret Masterson, Angela K. Smith, John Glod, John A. Zebala, Stacey Lisi, Drew-Anne Drapala, Barton A. Kamen. (2008) Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology 62:1, 65-75
CrossRef76
J. David Spence. (2008) Polypill: for Pollyanna. International Journal of Stroke 3:2, 92-97
CrossRef77
Helene McNulty, Kristina Pentieva, Leane Hoey, Mary Ward. (2008) Homocysteine, B-vitamins and CVD. Proceedings of the Nutrition Society 67:02, 232-237
CrossRef78
David W. Morris, Madhukar H. Trivedi, A. John Rush. (2008) Folate and Unipolar Depression. The Journal of Alternative and Complementary Medicine 14:3, 277-285
CrossRef79
Anne M. Molloy. 2008. Nutritional Determinants of Plasma Homocysteine: Implications for Risk of Cardiovascular Disease. , 40-47.
CrossRef80
Jan-Willem Muntjewerff, Henkjan Gellekink, Martin den Heijer, Mechteld L.C. Hoogendoorn, René S. Kahn, Richard J. Sinke, Henk J. Blom. (2008) Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia. European Neuropsychopharmacology 18:2, 99-106
CrossRef81
Linda Van Horn, Mikelle McCoin, Penny M. Kris-Etherton, Frances Burke, Jo Ann S. Carson, Catherine M. Champagne, Wahida Karmally, Geeta Sikand. (2008) The Evidence for Dietary Prevention and Treatment of Cardiovascular Disease. Journal of the American Dietetic Association 108:2, 287-331
CrossRef82
Chandrika J. Piyathilake, Jorge E. Celedonio, Maurizio Macaluso, Walter C. Bell, Maria Azrad, William E. Grizzle. (2008) Mandatory fortification with folic acid in the United States is associated with increased expression of DNA methyltransferase-1 in the cervix. Nutrition 24:1, 94-99
CrossRef83
George C. Ntaios, Christos G. Savopoulos, Anastasia C. Chatzinikolaou, Georgia D. Kaiafa, Apostolos Hatzitolios. (2008) Vitamins and Stroke. The Neurologist 14:1, 2-4
CrossRef84
RICHARD B. JOHNSTON. (2008) Will Increasing Folic Acid in Fortified Grain Products Further Reduce Neural Tube Defects without Causing Harm?: Consideration of the Evidence. Pediatric Research 63:1, 2-8
CrossRef85
Nahid Yazdanpanah, M. Carola Zillikens, Fernando Rivadeneira, Robert de Jong, Jan Lindemans, André G. Uitterlinden, Huibert A.P. Pols, Joyce B.J. van Meurs. (2007) Effect of dietary B vitamins on BMD and risk of fracture in elderly men and women: The Rotterdam Study. Bone 41:6, 987-994
CrossRef86
Caroline Moats, Eric B. Rimm. (2007) Vitamin intake and risk of coronary disease: Observation versus intervention. Current Atherosclerosis Reports 9:6, 508-514
CrossRef87
Ahmad B. Sarwar, Ammar Sarwar, Boaz D. Rosen, Khurram Nasir. (2007) Measuring subclinical atherosclerosis: is homocysteine relevant?. Clinical Chemistry and Laboratory Medicine 45:12, 1667-1677
CrossRef88
Eva Lonn. (2007) Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?. Current Opinion in Internal Medicine 6:6, 600-606
CrossRef89
Madeleine Becker, David J. Axelrod, Olu Oyesanmi, Dimitri D. Markov, Elisabeth J. Shakin Kunkel. (2007) Hematologic Problems in Psychosomatic Medicine. Psychiatric Clinics of North America 30:4, 739-759
CrossRef90
Noel W. Solomons. (2007) Food Fortification with Folic Acid: Has the Other Shoe Dropped?. Nutrition Reviews 65:11, 512-515
CrossRef91
Bradley A. Maron, Joseph Loscalzo. (2007) Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?. Current Atherosclerosis Reports 9:5, 375-383
CrossRef92
Amany K. Elshorbagy, Abderrahim Oulhaj, Svetlana Konstantinova, Eha Nurk, Per M. Ueland, Grethe S. Tell, Ottar Nygård, Stein E. Vollset, Helga Refsum. (2007) Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: Use of statistical modeling to determine reference limits. Clinical Biochemistry 40:16-17, 1209-1218
CrossRef93
M. Achón, E. Alonso-Aperte, N. Úbeda, G. Varela-Moreiras. (2007) Supranormal dietary folic acid supplementation: effects on methionine metabolism in weanling rats. British Journal of Nutrition 98:03, 490
CrossRef94
José A Luchsinger. (2007) Folate, related vitamins and risk of Alzheimer’s disease. Expert Review of Endocrinology & Metabolism 2:5, 559-561
CrossRef95
J David Spence. (2007) Homocysteine-lowering therapy: a role in stroke prevention?. The Lancet Neurology 6:9, 830-838
CrossRef96
Judith Moreines, Richard Cotter, Leon Ellenbogen. 2007. Potential Benefits for the Use of Vitamin and Mineral Supplements. , 193-219.
CrossRef97
Emel Köseoglu, Yahya Karaman. (2007) Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease. Clinical Biochemistry 40:12, 859-863
CrossRef98
Arturo J Martí-Carvajal, Georgia Salanti, Ricardo Hidalgo, Agustín Ciapponi, Arturo J Martí-Carvajal. 2007. Homocysteine lowering interventions for preventing cardiovascular events. .
CrossRef99
Joshua Miller, Ralph Green. 2007. Vitamin B12. .
CrossRef100
Joanie B. Wilson, Michael Welsch, Jason Allen, Jessica Thomson, Richard Tulley, Michael Lefevre. (2007) The association of homocysteine and related factors to brachial artery diameter and flow-mediated dilation. Metabolism 56:5, 641-648
CrossRef101
Young-In Kim. (2007) Folate and colorectal cancer: An evidence-based critical review. Molecular Nutrition & Food Research 51:3, 267-292
CrossRef102
Chandrika J. Piyathilake, Maria Azrad, Maurizio Macaluso, Gary L. Johanning, Phillip E. Cornwell, Edward E. Partridge, Douglas C. Heimburger. (2007) Protective association of MTHFR polymorphism on cervical intraepithelial neoplasia is modified by riboflavin status. Nutrition 23:3, 229-235
CrossRef103
Arturo J Martí-Carvajal, Ivan Solà, Arturo J Martí-Carvajal. 2007. Treatment for anemia in people with AIDS. .
CrossRef104
P Henríquez, J Doreste, R Deulofeu, M D Fiuza, L Serra-Majem. (2007) Nutritional determinants of plasma total homocysteine distribution in the Canary Islands. European Journal of Clinical Nutrition 61:1, 111-118
CrossRef105
SE Greenwald. (2007) Ageing of the conduit arteries. The Journal of Pathology 211:2, 157-172
CrossRef106
Gillian Lindzon, Deborah L. O'Connor. (2007) Folate during reproduction: the Canadian experience with folic acid fortification. Nutrition Research and Practice 1:3, 163
CrossRef107
Mahsa M. Yazdy, Margaret A. Honein, Jian Xing. (2007) Reduction in orofacial clefts following folic acid fortification of the U.S. grain supply. Birth Defects Research Part A: Clinical and Molecular Teratology 79:1, 16-23
CrossRef108
N Mito, H Takimoto, K Umegaki, A Ishiwaki, K Kusama, H Fukuoka, S Ohta, S Abe, M Yamawaki, H Ishida, N Yoshiike. (2007) Folate intakes and folate biomarker profiles of pregnant Japanese women in the first trimester. European Journal of Clinical Nutrition 61:1, 83-90
CrossRef109
William R. Hiatt. 2007. Peripheral Arterial Disease. , 379-388.
CrossRef110
Indu B. Ahluwalia, Jean M. Lawrence, Lina Balluz. (2006) Psychosocial Factors Associated With Use Of Multivitamins By Women Of Childbearing Age. Journal of Community Health 32:1, 57-69
CrossRef111
Jae Hee Kang, Michael C. Irizarry, Francine Grodstein. (2006) Prospective Study of Plasma Folate, Vitamin B12, and Cognitive Function and Decline. Epidemiology 17:6, 650-657
CrossRef112
T. G.K. Bentley, W. C. Willett, M. C. Weinstein, K. M. Kuntz. (2006) Population-Level Changes in Folate Intake by Age, Gender, and Race/Ethnicity after Folic Acid Fortification. American Journal of Public Health 96:11, 2040-2047
CrossRef113
Zoran Todorović, Eleonora Džoljić, Ivana Novaković, Duško Mirković, Radan Stojanović, Zorica Nešić, Maja Krajinović, Milica Prostran, Vladimir Kostić. (2006) Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy. Journal of the Neurological Sciences 248:1-2, 56-61
CrossRef114
V. Hach-Wunderle, M. Zegelman, W. Hach. (2006) Thrombophile Gerinnungsstörungen bei peripherer arterieller Verschlusskrankheit. Gefässchirurgie 11:5, 325-333
CrossRef115
María Elena Martínez, Edward Giovannucci, Ruiyun Jiang, Susanne M. Henning, Elizabeth T. Jacobs, Patricia Thompson, Stephanie A. Smith-Warner, David S. Alberts. (2006) Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. International Journal of Cancer 119:6, 1440-1446
CrossRef116
T S Bowman, J M Gaziano, M J Stampfer, H D Sesso. (2006) Homocysteine and risk of developing hypertension in men. Journal of Human Hypertension 20:8, 631-634
CrossRef117
Paul Cimoch, Susan Allen-Evenson, Jill Place, David Grotto, Ellyn Silverman. 2006. Immune System. .
CrossRef118
Julie A Schneider, Christy C Tangney, Martha Clare Morris. (2006) Folic acid and cognition in older persons. Expert Opinion on Drug Safety 5:4, 511-522
CrossRef119
Arduino A. Mangoni. (2006) Folic acid, inflammation, and atherosclerosis: False hopes or the need for better trials?. Clinica Chimica Acta 367:1-2, 11-19
CrossRef120
Gian Paolo Rossi, Giuseppe Maiolino, Teresa Maria Seccia, Alberto Burlina, Silvia Zavattiero, Maurizio Cesari, Daniele Sticchi, Luigi Pedon, Mario Zanchetta, Achille C Pessina. (2006) Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. Journal of Hypertension 24:5, 851-859
CrossRef121
Young Sik Lee, Doug Hyun Han, Chang Moo Jeon, In Kyoon Lyoo, Chul Na, Seok Lae Chae, Soo Churl Cho. (2006) Serum homocysteine, folate level and methylenetetrahydrofolate reductase 677, 1298 gene polymorphism in Korean schizophrenic patients. NeuroReport 17:7, 743-746
CrossRef122
Bønaa, Kaare Harald, Njølstad, Inger, Ueland, Per Magne, Schirmer, Henrik, Tverdal, Aage, Steigen, Terje, Wang, Harald, Nordrehaug, Jan Erik, Arnesen, Egil, Rasmussen, Knut, . (2006) Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction. New England Journal of Medicine 354:15, 1578-1588
Full Text123
K. T. Shenoy, K. B. Lena, N. Sali, S. Syam, S. T. Shenoy, V. D. Rajadhyaksha, G. P. Pai, A. A. Shaikh. (2006) Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia:an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation)*. Current Medical Research and Opinion 22:4, 641-648
CrossRef124
Angelo Del Parigi, Francesco Panza, Cristiano Capurso, Vincenzo Solfrizzi. (2006) Nutritional factors, cognitive decline, and dementia. Brain Research Bulletin 69:1, 1-19
CrossRef125
Sasidhar Guthikonda, William G. Haynes. (2006) Homocysteine: Role and implications in atherosclerosis. Current Atherosclerosis Reports 8:2, 100-106
CrossRef126
Jean M. Lawrence, Margaret L. Watkins, Vicki Chiu, J. David Erickson, Diana B. Petitti. (2006) Do racial and ethnic differences in serum folate values exist after food fortification with folic acid?. American Journal of Obstetrics and Gynecology 194:2, 520-526
CrossRef127
Kathy Jabs, Mark J. Koury, William D. Dupont, Conrad Wagner. (2006) Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children. Metabolism 55:2, 252-257
CrossRef128
Meyling H Cheok, Sanne Lugthart, William E. Evans. (2006) PHARMACOGENOMICS OF ACUTE LEUKEMIA. Annual Review of Pharmacology and Toxicology 46:1, 317-353
CrossRef129
P M Finglas, K de Meer, A Molloy, P Verhoef, K Pietrzik, H J Powers, D van der Straeten, M Jägerstad, G Varela-Moreiras, T van Vliet, R Havenaar, J Buttriss, A J A Wright. (2006) Research goals for folate and related B vitamin in Europe. European Journal of Clinical Nutrition 60:2, 287-294
CrossRef130
I. J. Kullo, G. Li, L. F. Bielak, K. R. Bailey, P. F. Sheedy, P. A. Peyser, S. T. Turner, S. L. R. Kardia. (2006) Association of Plasma Homocysteine With Coronary Artery Calcification in Different Categories of Coronary Heart Disease Risk. Mayo Clinic Proceedings 81:2, 177-182
CrossRef131
Graeme J Hankey. (2006) Is plasma homocysteine a modifiable risk factor for stroke?. Nature Clinical Practice Neurology 2:1, 26-33
CrossRef132
Eva Lonn. (2006) Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: The Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Canadian Journal of Cardiology 22:1, 47-53
CrossRef133
Cynthia M Carlsson. (2006) Homocysteine Lowering with Folic Acid and Vitamin B Supplements. Drugs & Aging 23:6, 491-502
CrossRef134
Mario Klingler, Astrid Blaschitz, Christina Campoy, Ana Caño, Anne M Molloy, John M Scott, Gottfried Dohr, Hans Demmelmair, Berthold Koletzko, Gernot Desoye. (2006) The effect of docosahexaenoic acid and folic acid supplementation on placental apoptosis and proliferation. British Journal of Nutrition 96:01, 182
CrossRef135
Helmi L. Lutsep, Stephen Campbell, Lloyd E. Chambless, Virginia J. Howard, James F. Toole. (2006) Plasma Total Homocysteine Levels in Stroke Patients Screened for the Vitamin Intervention for Stroke Prevention Clinical Trial in the Era of Folate Fortification. Neuroepidemiology 26:1, 45-51
CrossRef136
Sanja Simić-Ogrizović, Dragana Radivojević, Milan Radovic, Višnja Ležaic, Dusan Mirković, Dusan Babić, Ljubica Dukanović. (2006) Factors Associated with Hyperhomocysteinemia After Renal Transplantation. Renal Failure 28:1, 57-62
CrossRef137
2006. Antianginal drugs. , 260-263.
CrossRef138
R. Tarr, M. Pufulete. (2005) Folate and colorectal cancer - a review of the current evidence. Nutrition Bulletin 30:4, 356-363
CrossRef139
K de Meer, Y M Smulders, J R Dainty, D E C Smith, R M Kok, C D A Stehouwer, P M Finglas, C Jakobs. (2005) [6S]5-methyltetrahydrofolate or folic acid supplementation and absorption and initial elimination of folate in young and middle-aged adults. European Journal of Clinical Nutrition 59:12, 1409-1416
CrossRef140
Ralph Green, Joshua W. Miller. (2005) Vitamin B 12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clinical Chemistry and Laboratory Medicine 43:10, 1048-1051
CrossRef141
Michael A. Robbins, Merrill F. Elias, Marc M. Budge, Suzanne L. Brennan, Penelope K. Elias. (2005) Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study. Clinical Chemistry and Laboratory Medicine 43:10, 1101-1106
CrossRef142
Johan Sundström, Ramachandran S. Vasan. (2005) Homocysteine and heart failure: a review of investigations from the Framingham Heart Study. Clinical Chemistry and Laboratory Medicine 43:10, 987-992
CrossRef143
Kilmer S. McCully. (2005) Hyperhomocysteinemia and arteriosclerosis: historical perspectives. Clinical Chemistry and Laboratory Medicine 43:10, 980-986
CrossRef144
H.-K. Kuo, F. A. Sorond, J.-H. Chen, A. Hashmi, W. P. Milberg, L. A. Lipsitz. (2005) The Role of Homocysteine in Multisystem Age-Related Problems: A Systematic Review. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:9, 1190-1201
CrossRef145
James Layne Moore. (2005) The significance of folic acid for epilepsy patients. Epilepsy & Behavior 7:2, 172-181
CrossRef146
Sonia Hern??ndez-D??az, Xiao F. Wu, Catherine Hayes, Martha M. Werler, Tara Devi S. Ashok, Rachel Badovinac, Karl T. Kelsey, Allen A. Mitchell. (2005) Methylenetetrahydrofolate Reductase Polymorphisms and the Risk of Gestational Hypertension. Epidemiology 16:5, 628-634
CrossRef147
Angelika de Bree, Pilar Galan, Louise Mennen. 2005. The Role of Complementary Vitamins, Folate, Vitamin B6, and Vitamin B12, in Cardiovascular Disease. , 77-109.
CrossRef148
Siobhan Hickling, Matthew Knuiman, Konrad Jamrozik, Joseph Hung. (2005) A rapid dietary assessment tool to determine intake of folate was developed and validated. Journal of Clinical Epidemiology 58:8, 802-808
CrossRef149
G. J. HANKEY. (2005) Preventable stroke and stroke prevention. Journal of Thrombosis and Haemostasis 3:8, 1638-1645
CrossRef150
Mark G. Davies, David L. Waldman, Thomas A. Pearson. (2005) Comprehensive Endovascular Therapy for Femoropopliteal Arterial Atherosclerotic Occlusive Disease. Journal of the American College of Surgeons 201:2, 275-296
CrossRef151
John H.K. Vogel, Steven F. Bolling, Rebecca B. Costello, Erminia M. Guarneri, Mitchell W. Krucoff, John C. Longhurst, Brian Olshansky, Kenneth R. Pelletier, Cynthia M. Tracy, Robert A. Vogel, Robert A. Vogel, Jonathan Abrams, Jeffrey L. Anderson, Eric R. Bates, Bruce R. Brodie, Cindy L. Grines, Peter G. Danias, Gabriel Gregoratos, Mark A. Hlatky, Judith S. Hochman, Sanjiv Kaul, Robert C. Lichtenberg, Jonathan R. Lindner, Robert A. O’Rourke, Gerald M. Pohost, Richard S. Schofield, Samuel J. Shubrooks, Cynthia M. Tracy, William L. Winters. (2005) Integrating Complementary Medicine Into Cardiovascular Medicine. Journal of the American College of Cardiology 46:1, 184-221
CrossRef152
Jesse F. Gregory, Eoin P. Quinlivan, Steven R. Davis. (2005) Integrating the issues of folate bioavailability, intake and metabolism in the era of fortification. Trends in Food Science & Technology 16:6-7, 229-240
CrossRef153
Anne M. Molloy. (2005) The role of folic acid in the prevention of neural tube defects. Trends in Food Science & Technology 16:6-7, 241-245
CrossRef154
Barry E. Gidal, T. Tamura, Anne Hammer, Alain Vuong. (2005) Blood homocysteine, folate and Vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy. Epilepsy Research 64:3, 161-166
CrossRef155
Koichi Miyaki, Mitsuru Murata, Haruhito Kikuchi, Izumi Takei, Takeo Nakayama, Kiyoaki Watanabe, Kazuyuki Omae. (2005) Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype. Journal of Human Genetics 50:5, 241-248
CrossRef156
Generoso Andria, Iris Scala, Gianfranco Sebastio. (2005) Health implications of homocysteine and folates: possible preventive measures. Nutrition, Metabolism and Cardiovascular Diseases 15:2, 87-93
CrossRef157
Caroline Signore, James L. Mills, Christopher Cox, Ann C. Trumble. (2005) Effects of Folic Acid Fortification on Twin Gestation Rates. Obstetrics & Gynecology 105:4, 757-762
CrossRef158
Atsuo Kondo, Osamu Kamihira, Yoichi Shimosuka, Ikuyo Okai, Momokazu Gotoh, Hideo Ozawa. (2005) Awareness of the role of folic acid, dietary folate intake and plasma folate concentration in Japan. Journal of Obstetrics and Gynaecology Research 31:2, 172-177
CrossRef159
Maurizio Cesari, Gian Paolo Rossi, Daniele Sticchi, Achille C. Pessina. (2005) Is homocysteine important as risk factor for coronary heart disease?. Nutrition, Metabolism and Cardiovascular Diseases 15:2, 140-147
CrossRef160
Joan Llevadot, Francisco Blanco Vaca, Francesc González Sastre. (2005) Determinación y utilización de la concentración plasmática de homocisteína en la práctica clínica. Medicina Clínica 124:14, 544-553
CrossRef161
Alice H Lichtenstein. (2005) Nutrients and cardiovascular disease: no easy answers – editorial review. Current Opinion in Lipidology 16:1, 1-3
CrossRef162
I. J. Kullo, C. M. Ballantyne. (2005) Conditional Risk Factors for Atherosclerosis. Mayo Clinic Proceedings 80:2, 219-230
CrossRef163
Kaori Yoshino, Mieko Inagawa, Miyuki Oshima, Kimiko Yokota, Mitsumasa Umesawa, Ma Enbo, Kazumasa Yamagishi, Takeshi Tanigawa, Shinichi Sato, Takashi Shimamoto, Hiroyasu Iso. (2005) Trends in Dietary Intake of Folate, Vitamins B6, and B12 among Japanese Adults in Two Rural Communities from 1974 through 2001. Journal of Epidemiology 15:2, 29-37
CrossRef164
Norberto Andaluz, Mario Zuccarello. (2005) Place of Drug Therapy in the Treatment of Carotid Stenosis. CNS Drugs 19:7, 597-622
CrossRef165
Margaret S. Clark, Janet R. Guthrie, Lorraine Dennerstein. (2005) Hyperhomocysteinemia Is Associated with Lower Performance on Memory Tasks in Post-Menopausal Women. Dementia and Geriatric Cognitive Disorders 20:2-3, 57-62
CrossRef166
Kevin D. Cashman. (2005) Homocysteine and Osteoporotic Fracture Risk: A Potential Role for B Vitamins. Nutrition Reviews 63:1, 29-36
CrossRef167
J.W. Miller. 2005. HOMOCYSTEINE. , 462-469.
CrossRef168
T. LATIF, E. D. HSI, L. A. RYBICKI, D. J. ADELSTEIN. (2004) Is there a role for folate determinations in current clinical practice in the USA?. Clinical and Laboratory Haematology 26:6, 379-383
CrossRef169
J. J. Strain, L. Dowey, M. Ward, K. Pentieva, H. McNulty. (2004) B-vitamins, homocysteine metabolism and CVD. Proceedings of the Nutrition Society 63:04, 597-603
CrossRef170
Hsu-Ko Kuo. (2004) Relationship Between Homocysteine and Cardiovascular Diseases in Older Adults. Journal of the American Geriatrics Society 52:11, 1955-1956
CrossRef171
Ramin Mojtabai. (2004) Body mass index and serum folate in childbearing age women. European Journal of Epidemiology 19:11, 1029-1036
CrossRef172
Godfrey P. Oakley, Mary Beth Weber, Karen N. Bell, Paul Colditz. (2004) Scientific evidence supporting folic acid fortification of flour in Australia and New Zealand. Birth Defects Research Part A: Clinical and Molecular Teratology 70:11, 838-841
CrossRef173
Kim L. McBride, Susan Fernbach, Andres Menesses, Laura Molinari, Ellinor Quay, Ricardo Pignatelli, Jeffrey A. Towbin, John W. Belmont. (2004) A family-based association study of congenital left-sided heart malformations and 5,10 methylenetetrahydrofolate reductase. Birth Defects Research Part A: Clinical and Molecular Teratology 70:10, 825-830
CrossRef174
Sarah L. Morgan, Robert A. Oster, Jeannette Y. Lee, Graciela S. Alarc
n, Joseph E. Baggott. (2004) The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis & Rheumatism 50:10, 3104-3111
CrossRef175
J. Buttriss. (2004) Strategies to increase folate/folic acid intake in women: an overview. Nutrition Bulletin 29:3, 234-244
CrossRef176
Katherine L. Tucker. (2004) Dietary intake and coronary heart disease: A variety of nutrients and phytochemicals are important. Current Treatment Options in Cardiovascular Medicine 6:4, 291-302
CrossRef177
Mark J. Koury, Prem Ponka. (2004) NEW INSIGHTS INTO ERYTHROPOIESIS: The Roles of Folate, Vitamin B 12 , and Iron* 1. Annual Review of Nutrition 24:1, 105-131
CrossRef178
Beth H. Olson, Debra R. Keast, Won O. Song, Diane H. Morris. (2004) Effectiveness and Safety of Folic Acid Fortification. Nutrition Today 39:4, 169-175
CrossRef179
Lange, Helmut, Suryapranata, Harry, De Luca, Giuseppe, Börner, Caspar, Dille, Joep, Kallmayer, Klaus, Pasalary, M. Noor, Scherer, Eberhard, Dambrink, Jan-Henk E., . (2004) Folate Therapy and In-Stent Restenosis after Coronary Stenting. New England Journal of Medicine 350:26, 2673-2681
Full Text180
Herrmann, Howard C., . (2004) Prevention of Cardiovascular Events after Percutaneous Coronary Intervention. New England Journal of Medicine 350:26, 2708-2710
Full Text181
Elizabeth A Yetley, Jeanne I. Rader. (2004) Modeling the Level of Fortification and Post-Fortification Assessments: U.S. Experience. Nutrition Reviews 62, S50-S59
CrossRef182
George E. Vrentzos, John A. Papadakis, Niki Malliaraki, Evagelos A. Zacharis, Elias Mazokopakis, Andreas Margioris, Emmanuel S. Ganotakis, Anthony Kafatos. (2004) Diet, serum homocysteine levels and ischaemic heart disease in a Mediterranean population. British Journal of Nutrition 91:06, 1013
CrossRef183
Godfrey P. Oakley. (2004) Oral Synthetic Folic Acid and Vitamin B 12 Supplements Work-If One Consumes Them. Nutrition Reviews 62, S22-S26
CrossRef184
Patrick Brachet, Aurélie Chanson, Christian Demigné, Frédérique Batifoulier, Marie-Cécile Alexandre-Gouabau, Viviane Tyssandier, Edmond Rock. (2004) Age-associated B vitamin deficiency as a determinant of chronic diseases. Nutrition Research Reviews 17:01, 55
CrossRef185
Nataliya Yuskiv, Clark O. Andelin, Svitlana Polischuk, Oleksandr Shevchuk, Zoryana Sosynyuk, Tetyana Vihovska, Lyubov Yevtushok, Godfrey P. Oakley, Wladimir Wertelecki. (2004) High rates of neural tube defects in Ukraine. Birth Defects Research Part A: Clinical and Molecular Teratology 70:6, 400-402
CrossRef186
Lynn B. Bailey. (2004) Folate and Vitamin B 12 Recommended Intakes and Status in the United States. Nutrition Reviews 62, S14-S20
CrossRef187
McLean, Robert R., Jacques, Paul F., Selhub, Jacob, Tucker, Katherine L., Samelson, Elizabeth J., Broe, Kerry E., Hannan, Marian T., Cupples, L. Adrienne, Kiel, Douglas P., . (2004) Homocysteine as a Predictive Factor for Hip Fracture in Older Persons. New England Journal of Medicine 350:20, 2042-2049
Full Text188
James M Shikany, Douglas C Heimburger, Chandrika J Piyathilake, Renee A Desmond, Paul G Greene. (2004) Effect of folic acid fortification of foods on folate intake in female smokers with cervical dysplasia. Nutrition 20:5, 409-414
CrossRef189
Santiago G Miriuka, Loralie J Langman, Eitan S Keren, Steven E.S Miner, Orval A Mamer, Diego H Delgado, Jovan Evrovski, Heather J Ross, David E.C Cole. (2004) Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin b12 status in cardiac transplant recipients. The Journal of Heart and Lung Transplantation 23:4, 405-412
CrossRef190
Robert R McLean, David Karasik, Jacob Selhub, Katherine L Tucker, Jose M Ordovas, Giuseppina T Russo, L Adrienne Cupples, Paul F Jacques, Douglas P Kiel. (2004) Association of a Common Polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) Gene With Bone Phenotypes Depends on Plasma Folate Status. Journal of Bone and Mineral Research 19:3, 410-418
CrossRef191
JOSHUA W. MILLER. (2004) Folate, Cognition, and Depression in the Era of Folic Acid Fortification. Journal of Food Science 69:1, SNQ61-SNQ65
CrossRef192
Danyelle M Townsend, Kenneth D Tew, Haim Tapiero. (2004) Sulfur containing amino acids and human disease. Biomedicine & Pharmacotherapy 58:1, 47-55
CrossRef193
EJ Wiltshire, JJ Couper. (2004) Improved folate status in children and adolescents during voluntary fortification of food with folate. Journal of Paediatrics and Child Health 40:1-2, 44-47
CrossRef194
Young-In Kim. (2004) Folate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies. Environmental and Molecular Mutagenesis 44:1, 10-25
CrossRef195
JESSE F. G REGORY. (2004) Dietary Folate in a Changing Environment: Bioavailability, Fortification, and Requirements. Journal of Food Science 69:1, SNQ59-SNQ61
CrossRef196
Allon N. Friedman, Lawrence G. Hunsicker, Jacob Selhub, Andrew G. Bostom. (2004) Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis 172:1, 121-125
CrossRef197
Quanhe Yang, Michael Atkinson, J. David Erickson. (2003) Method of weighted proportion of reproductive-aged women taking folic acid supplements to predict a neural tube defect rate decline. Birth Defects Research Part A: Clinical and Molecular Teratology 67:12, 959-967
CrossRef198
Noah Samuels. (2003) Screening for homocysteine levels in Israel in primary care clinics: a need for guidelines. Preventive Medicine 37:6, 668-671
CrossRef199
Mark T Cahill, Sandra S Stinnett, Sharon Fekrat. (2003) Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. American Journal of Ophthalmology 136:6, 1136-1150
CrossRef200
Godfrey P. Oakley. (2003) Folate deficiency is an ?imminent health hazard? causing a worldwide birth defects epidemic. Birth Defects Research Part A: Clinical and Molecular Teratology 67:11, 903-904
CrossRef201
R Malouf, J Grimley Evans, A Areosa Sastre, Reem Malouf. 2003. Folic acid with or without vitamin B12 for cognition and dementia. .
CrossRef202
Santiago G Miriuka, Diego H Delgado, David E.C Cole, Vivek Rao, Heather J Ross. (2003) Hyperhomocysteinemia in heart transplantation: from bench to bedside. The Journal of Heart and Lung Transplantation 22:10, 1069-1081
CrossRef203
D. K. Waller, A. T. N. Tita, J. F. Annegers. (2003) Rates of twinning before and after fortification of foods in the US with folic acid, Texas, 1996 to 1998. Paediatric and Perinatal Epidemiology 17:4, 378-383
CrossRef204
L TAYLOR. (2003) Elevated plasma homocysteine as risk factor for peripheral arterial disease—what is the evidence?1. Seminars in Vascular Surgery 16:3, 215-222
CrossRef205
Paul M. Finglas, Anthony J. A. Wright, Caroline A. Wolfe, David J. Hart, Dawn M. Wright, Jack R. Dainty. (2003) Is there more to folates than neural-tube defects?. Proceedings of the Nutrition Society 62:03, 591-598
CrossRef206
Elizabeth Wrone, John Hornberger. (2003) Pharmacoeconomics of folic acid supplementation for cardiovascular disease prevention. Expert Review of Pharmacoeconomics & Outcomes Research 3:2, 159-167
CrossRef207
J. Lokk. (2003) News and Views on Folate and Elderly Persons. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 58:4, M354-M361
CrossRef208
Lynn L. Moore, M. Loring Bradlee, Martha R. Singer, Kenneth J. Rothman, Aubrey Milunsky. (2003) Folate Intake and the Risk of Neural Tube Defects: An Estimation of Dose-Response. Epidemiology 14:2, 200-205
CrossRef209
Harold Kalter. (2003) Teratology in the 20th century. Neurotoxicology and Teratology 25:2, 131-282
CrossRef210
Vivian A Fonseca, Louis M Fink, Philip A Kern. (2003) Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects. Atherosclerosis 167:1, 105-109
CrossRef211
Val??rie Biousse. (2003) The Coagulation System. Journal of Neuro-Ophthalmology 23:1, 50-62
CrossRef212
Marja-Leena Silaste, Maire Rantala, Georg Alfthan, Antti Aro, Y. Antero Kesäniemi. (2003) Plasma homocysteine concentration is decreased by dietary intervention. British Journal of Nutrition 89:03, 295
CrossRef213
Paul S. Aisen, Susan Egelko, Howard Andrews, Ramon Diaz-Arrastia, Myron Weiner, Charles DeCarli, William Jagust, Joshua W. Miller, Ralph Green, Karen Bell, Mary Sano. (2003) A Pilot Study of Vitamins to Lower Plasma Homocysteine Levels in Alzheimer Disease. American Journal of Geriatric Psychiatry 11:2, 246-249
CrossRef214
Setareh Torabian Esfahani, Edward A Cogger, Marie A Caudill. (2003) Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. Journal of the American Dietetic Association 103:2, 200-207
CrossRef215
Melissa R French, Susan I Barr, Ryna Levy-Milne. (2003) Folate intakes and awareness of folate to prevent neural tube defects: A survey of women living in Vancouver, Canada. Journal of the American Dietetic Association 103:2, 181-185
CrossRef216
C. M. Rosell. 2003. The nutritional enhancement of wheat flour. , 253-269.
CrossRef217
N.P. Hays, S.B. Roberts. 2003. AGING – NUTRITIONAL ASPECTS. , 81-87.
CrossRef218
Younghee Kim, Siusai Tse, Nancy Boudreau. (2002) Race/Ethnicity and Gender Differences in Hyperhomocysteinemia and Folate and Vitamin B 12 Status in American Elderly. Journal of Nutrition For the Elderly 22:2, 37-53
CrossRef219
Emmanouil S Brilakis, Joseph P McConnell, Karla V Ballman, George G Klee, Peter B Berger. (2002) Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid. Atherosclerosis 165:2, 375-381
CrossRef220
Sonia Hernández-Díaz, Ernesto Martínez-Losa, Elena Fernández-Jarne, Manuel Serrano-Martínez, Miguel A. Martínez-González. (2002) Dietary Folate and the Risk of Nonfatal Myocardial Infarction. Epidemiology 13:6, 700-706
CrossRef221
Sandra Hirsch, M. Pia De La Maza, Margarita M.Sc. Petermann, Gladys Barrera, Vivian Gattas, Edgardo Escobar, Paulina Yañez, Andrea Glasinovic, Daniel Bunout. (2002) Hyperhomocysteinemia and Endothelial Function in Young Subjects: Effects of Vitamin Supplementation. Clinical Cardiology 25:11, 495-501
CrossRef222
Bradley K. Hiatt, Steven R. Lentz. (2002) Prothrombotic states that predispose to stroke. Current Treatment Options in Neurology 4:6, 417-425
CrossRef223
Bhushan Kapur, Offie Porat Soldin, Gideon Koren. (2002) Potential Prevention of Neural Tube Defects by Assessment of Women of Childbearing Age Through Monitoring of Folate. Therapeutic Drug Monitoring 24:5, 628-630
CrossRef224
Peter J. Kelly, Karen L. Furie. (2002) Management and prevention of stroke associated with elevated homocysteine. Current Treatment Options in Cardiovascular Medicine 4:5, 363-371
CrossRef225
Yoshihiro Sato, Masahide Kaji, Izumi Kondo, Hidemi Yoshida, Kei Satoh, Norifumi Metoki. (2002) Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: Effect of combined therapy with folic acid and mecobalamine. Journal of the Neurological Sciences 202:1-2, 65-68
CrossRef226
Andrea Irvin-Jones. (2002) Lowering Plasma Homocyst(e)ine May Affect Atherosclerotic Disease. The Nurse Practitioner 27:10, 52-54
CrossRef227
Mutsuo Yamaya, Takashi Ohrui, Hiroshi Kubo, Satoru Ebihara, Hiroyuki Arai, Hidetada Sasaki. (2002) Prevention of respiratory infections in the elderly. Geriatrics and Gerontology International 2:3, 115-121
CrossRef228
JI Mann. (2002) Diet and risk of coronary heart disease and type 2 diabetes. The Lancet 360:9335, 783-789
CrossRef229
Frédéric Guay, J. Jacques Matte, Christiane L. Girard, Marie-France Palin, Alain Giguère, Jean-Paul Laforest. (2002) Effects of folic acid and vitamin B12 supplements on folate and homocysteine metabolism in pigs during early pregnancy. British Journal of Nutrition 88:03, 253
CrossRef230
Conrad Earnest, Kenneth H Cooper, Angela Marks, Tedd L Mitchell. (2002) Efficacy of a complex multivitamin supplement. Nutrition 18:9, 738-742
CrossRef231
Harold Kalter. (2002) Folic acid and NTD?continued: Genetic variants. Teratology 66:2, 55-56
CrossRef232
Richard S. Olney, Joseph Mulinare. (2002) Trends in neural tube defect prevalence, folic acid fortification, and vitamin supplement use. Seminars in Perinatology 26:4, 277-285
CrossRef233
Godfrey P. Oakley. (2002) Inertia on folic acid fortification: Public health malpractice. Teratology 66:1, 44-54
CrossRef234
Ralph Carmel, Padmaja V. Mallidi, Simon Vinarskiy, Shabneet Brar, Zohreh Frouhar. (2002) Hyperhomocysteinemia and cobalamin deficiency in young Asian Indians in the United States. American Journal of Hematology 70:2, 107-114
CrossRef235
Don C Dyke, Phyllis J Stumbo, Mary J Berg Pharm, Jennifer R Niebyl. (2002) Folic acid and prevention of birth defects. Developmental Medicine & Child Neurology 44:6, 426-429
CrossRef236
Alan Cheng, Joel B. Braunstein, Cheryl Dennison, Caitlin Nass, Roger S. Blumenthal. (2002) Reducing global risk for cardiovascular disease: Using lifestyle changes and pharmacotherapy. Clinical Cardiology 25:5, 205-212
CrossRef237
Martha Savaria Morris. (2002) Folate, Homocysteine, and Neurological Function. Nutrition in Clinical Care 5:3, 124-132
CrossRef238
Julianne S. Collins, Rick L. Olson, Barbara R. DuPont, Daynna J. Wolff, Robert G. Best, Roger E. Stevenson. (2002) Prevalence of aneuploidies in South Carolina in the 1990s. Genetics in Medicine 4:3, 131-135
CrossRef239
Allon N. Friedman, Irwin H. Rosenberg, Jacob Selhub, Andrew S. Levey, Andrew G. Bostom. (2002) Hyperhomocysteinemia in Renal Transplant Recipients. American Journal of Transplantation 2:4, 308-313
CrossRef240
Suparna Rajan, Jeffrey I. Wallace, Shirley A. A. Beresford, Kayla I. Brodkin, Robert A. Allen, Sally P. Stabler. (2002) Screening for Cobalamin Deficiency in Geriatric Outpatients: Prevalence and Influence of Synthetic Cobalamin Intake. Journal of the American Geriatrics Society 50:4, 624-630
CrossRef241
Graeme J. Hankey. (2002) Is homocysteine a causal and treatable risk factor for vascular diseases of the brain (cognitive impairment and stroke)?. Annals of Neurology 51:3, 279-281
CrossRef242
Joel G. Ray, Marian J. Vermeulen, Sheila C. Boss, David E. C. Cole. (2002) Increased Red Cell Folate Concentrations in Women of Reproductive Age after Canadian Folic Acid Food Fortification. Epidemiology 13:2, 238-240
CrossRef243
Seshadri, Sudha, Beiser, Alexa, Selhub, Jacob, Jacques, Paul F., Rosenberg, Irwin H., D'Agostino, Ralph B., Wilson, Peter W.F., Wolf, Philip A., . (2002) Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease. New England Journal of Medicine 346:7, 476-483
Full Text244
Allon N. Friedman. (2002) Pharmacologic B-Vitamin Therapy for Hyperhomocysteinemia in Dialysis Patients: Has the Time Come?. Nutrition in Clinical Care 5:1, 20-24
CrossRef245
Kelley E Johnston, Philip A Lofgren, Tsunenobu Tamura. (2002) Folate concentrations of fast foods measured by trienzyme extraction method. Food Research International 35:6, 565-569
CrossRef246
Brahmajee K. Nallamothu, A. Mark Fendrick, Gilbert S. Omenn. (2002) Homocyst(e)ine and Coronary Heart Disease. PharmacoEconomics 20:7, 429-442
CrossRef247
Marcia Feldkamp, Michael Friedrichs, John C. Carey. (2002) Decreasing prevalence of neural tube defects in Utah, 1985-2000. Teratology 66:S1, S23-S28
CrossRef248
Gideon Koren, Gil Klinger, Arne Ohlsson. (2002) Fetal Pharmacotherapy. Drugs 62:5, 757-773
CrossRef249
Michael J. Davidoff, Joann Petrini, Karla Damus, Rebecca B. Russell, Donald Mattison. (2002) Neural tube defect-specific infant mortality in the United States. Teratology 66:S1, S17-S22
CrossRef250
Willett, Walter C., Stampfer, Meir J., . (2001) What Vitamins Should I Be Taking, Doctor?. New England Journal of Medicine 345:25, 1819-1824
Full Text251
David M. Colquhoun. (2001) Nutraceuticals: vitamins and other nutrients in coronary heart disease. Current Opinion in Lipidology 12:6, 639-646
CrossRef252
Ingeborg A. Brouwer, Maryke van Dusseldorp, Clive E. West, Régine P.M. Steegers-Theunissen. (2001) Bioavailability and bioefficacy of folate and folic acid in man. Nutrition Research Reviews 14:02, 267
CrossRef253
NJ Wald, MR Law, JK Morris, DS Wald. (2001) Quantifying the effect of folic acid. The Lancet 358:9298, 2069-2073
CrossRef254
Emi Sato, Takashi Ohrui, Toshifumi Matsui, Hiroyuki Arai, Hidetada Sasaki. (2001) Folate Deficiency and Risk of Pneumonia in Older People. Journal of the American Geriatrics Society 49:12, 1739-1741
CrossRef255
Sigrid Gibson. (2001) Dietary sugars and micronutrient dilution in normal adults aged 65 years and over. Public Health Nutrition 4:06,
CrossRef256
Marie Chantal Audelin, Jacques Genest. (2001) Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis 159:2, 497-511
CrossRef257
Manohara P. J. Senaratne, Karen Macdonald, Dilshana De Silva. (2001) Possible ethnic differences in plasma homocysteine levels associated with coronary artery disease between south asian and east asian immigrants. Clinical Cardiology 24:11, 730-734
CrossRef258
G Franklin Carl. 2001. Nutritional Therapies for Neurological and Psychiatric Disorders. .
CrossRef259
Allen Perelson, Leon Ellenbogen. 2001. Rationale for Use of Vitamin and Mineral Supplements. .
CrossRef260
Carol J. Boushey, Julianne W. Edmonds, Kathleen J. Welshimer. (2001) Estimates of the effects of folic-acid fortification and folic-acid bioavailability for women. Nutrition 17:10, 873-879
CrossRef261
P. J. Moynihan, A. J. Rugg-Gunn, T. J. Butler, A. J. Adamson. (2001) Dietary intake of folate by adolescents and the potential effect of flour fortification with folic acid. British Journal of Nutrition 86:04, 529
CrossRef262
LINDA VAN HORN, NANCY ERNST. (2001) A Summary of the Science Supporting the New National Cholesterol Education Program Dietary Recommendations. Journal of the American Dietetic Association 101:10, 1148-1154
CrossRef263
Coen DA Stehouwer, Coen van Guldener. (2001) Homocysteine-lowering treatment: an overview. Expert Opinion on Pharmacotherapy 2:9, 1449-1460
CrossRef264
Sotirios Vasilopoulos, Kia Saiean, Jeanne Emmons, William L. Berger, Majed Abu-Hajir, Bellur Seetharam, David G. Binion. (2001) Terminal Ileum Resection Is Associated With Higher Plasma Homocysteine Levels in Crohn's Disease. Journal of Clinical Gastroenterology 33:2, 132-136
CrossRef265
Derval J Gaughan, Leo A.J Kluijtmans, Sandrine Barbaux, Dorothy McMaster, Ian S Young, John W.G Yarnell, Alun Evans, Alexander S Whitehead. (2001) The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157:2, 451-456
CrossRef266
Hans J. Naurath, Reiner Riezler, Sigurd Pütter, Johan B. Ubbink. (2001) Does a Single Vitamin B-Supplementation Induce Functional Vitamin B-Deficiency?. Clinical Chemistry and Laboratory Medicine 39:8, 768-771
CrossRef267
Rafael J. Gaytan, L. Michael Prisant. (2001) Oral Nutritional Supplements and Heart Disease: A Review. American Journal of Therapeutics 8:4, 255-274
CrossRef268
A. V. Hoffbrand, D. G. Weir. (2001) The history of folic acid. British Journal of Haematology 113:3, 579-589
CrossRef269
Wood, Alastair J.J., , Hiatt, William R., . (2001) Medical Treatment of Peripheral Arterial Disease and Claudication. New England Journal of Medicine 344:21, 1608-1621
Full Text270
Allan V Hoffbrand. 2001. Folate Deficiency in Humans. .
CrossRef271
Mara Prengler, Natalie Sturt, Steve Krywawych, Robert Surtees, Raina Liesner, Fenella Kirkham. (2001) Homozygous thermolabile variant of the methylenetetrahy-drofolate reductase gene: a potential risk factor for hyperhomo-cysteinaemia, CVD, and stroke in childhood. Developmental Medicine & Child Neurology 43:4, 220-225
CrossRef272
R ZHAO, F GAO, I GOLDMAN. (2001) Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells. Biochemical Pharmacology 61:7, 857-865
CrossRef273
Tay S. Kennedy, Ellen B. Fung, Deborah A. Kawchak, Babette S. Zemel, Kwaku Ohene-Frempong, Virginia A. Stallings. (2001) Red Blood Cell Folate and Serum Vitamin B12 Status in Children With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology 23:3, 165-169
CrossRef274
Padmaja R. Itikala, Margaret L. Watkins, Joseph Mulinare, Cynthia A. Moore, Yecai Liu. (2001) Maternal multivitamin use and orofacial clefts in offspring. Teratology 63:2, 79-86
CrossRef275
MARY J BERG, DON C VANDYKE, CATHY CHENARD, JENNIFER R NIEBYL, SARAPEE HIRANKARN, ADRIANNE BENDICH, PHYLLIS STUMBO. (2001) Folate, Zinc, and Vitamin B-12 Intake During Pregnancy and Postpartum. Journal of the American Dietetic Association 101:2, 242-245
CrossRef276
Robert Loncar, Vedran Hrboka, Vera Tabakovic-Loncar, Zdenko Ostojic, Andreas Deussen. (2001) Screening of plasma homocysteine in peripheral arterial disease. Annals of Medicine 33:1, 48-54
CrossRef277
M. René Malinow, P. Barton Duell, Michelle A. Williams, Warren D. Kruger, Alison A. Evans, Peter H. Anderson, Peter C. Block, David L. Hess, Barbara M. Upson, Eric E. Graf, Andrea Irvin-Jones, Liqun Wang. (2001) Short-term folic acid supplementation induces variable and paradoxical changes in plasma homocyst(e)ine concentrations. Lipids 36:S1, S27-S32
CrossRef278
Marco Cattaneo. (2001) Hyperhomocysteinemia and thrombosis. Lipids 36:S1, S13-S26
CrossRef279
Graeme J. Hankey, John W. Eikelboom. (2001) Homocysteine Levels in Patients with Stroke. CNS Drugs 15:6, 437-443
CrossRef280
Ian M. Graham, Patrick O??Callaghan. (2000) The role of folic acid in the prevention of cardiovascular disease. Current Opinion in Lipidology 11:6, 577-587
CrossRef281
Andrew E. Czeizel. (2000) Primary Prevention of Neural-Tube Defects and Some Other Major Congenital Abnormalities. Paediatric Drugs 2:6, 437-449
CrossRef282
Gere Sunder-Plassmann, Wolfgang C Winkelmayer, Manuela Födinger. (2000) Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease. Expert Opinion on Investigational Drugs 9:11, 2637-2652
CrossRef283
Lawrence M Title, Peter M Cummings, Karen Giddens, Jacques J Genest, Bassam A Nassar. (2000) Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. Journal of the American College of Cardiology 36:3, 758-765
CrossRef284
Peter W.F. Wilson. (2000) Homocysteine: The New Risk Factor for Cardiovascular Disease in the Elderly. The American Journal of Geriatric Cardiology 9:4, 185-189
CrossRef285
Jonathan E Alpert, David Mischoulon, Andrew A Nierenberg, Maurizio Fava. (2000) Nutrition and depression: focus on folate. Nutrition 16:7-8, 544-546
CrossRef286
Joshua W Miller. (2000) Homocysteine, Alzheimer’s disease, and cognitive function. Nutrition 16:7-8, 675-677
CrossRef287
Joel G. Ray, David E.C. Cole, Sheila C. Boss. (2000) An Ontario-wide study of vitamin B12, serum folate, and red cell folate levels in relation to plasma homocysteine: is a preventable public health issue on the rise?. Clinical Biochemistry 33:5, 337-343
CrossRef288
M. Makris. (2000) Hyperhomocysteinemia and thrombosis. Clinical and Laboratory Haematology 22:3, 133-143
CrossRef289
Mills, James L., . (2000) Fortification of Foods with Folic Acid — How Much is Enough?. New England Journal of Medicine 342:19, 1442-1445
Full Text290
William G. Christen, Paul M. Ridker. (2000) Blood levels of homocysteine and atherosclerotic vascular disease. Current Atherosclerosis Reports 2:3, 194-199
CrossRef291
Michelle C. McKinley. (2000) Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease. Proceedings of the Nutrition Society 59:02, 221-237
CrossRef292
Coen D. Stehouwer. (2000) Clinical Relevance of Hyperhomocysteinaemia in Atherothrombotic Disease. Drugs & Aging 16:4, 251-260
CrossRef293
Gere Sunder-Plassmann, Andreas Floth, Manuela Födinger. (2000) Hyperhomocysteinemia in organ transplantation. Current Opinion in Urology 10:2, 87-94
CrossRef294
Riska Platt. (2000) Current Concepts in Optimum Nutrition for Cardiovascular Disease. Preventive Cardiology 3:2, 83-87
CrossRef295
Marvin A. Fishman. (2000) Birth defects and supplemental vitamins. Current Treatment Options in Neurology 2:2, 117-122
CrossRef296
Andrew G Bostom, Carol Garber. (2000) Endpoints for homocysteine-lowering trials. The Lancet 355:9203, 511-512
CrossRef297
Niranjan Seshadri, Killian Robinson. (2000) HOMOCYSTEINE, B VITAMINS, AND CORONARY ARTERY DISEASE. Medical Clinics of North America 84:1, 215-237
CrossRef298
Bruce N Ames, Lois Swirsky Gold. (2000) Paracelsus to parascience: the environmental cancer distraction. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 447:1, 3-13
CrossRef299
CA Michie, I Narang, J Rogers, A Robinson. (2000) Folate supplementation and neural-tube defects. The Lancet 355:9198, 147
CrossRef300
Val??rie Biousse. (1999) Coagulation abnormalities and their neuro-ophthalmologic manifestations. Current Opinion in Opthalmology 10:6, 382-393
CrossRef301
Robert E Meyer, Godfrey P Oakley Jr. (1999) Folic acid fortification. The Lancet 354:9196, 2168
CrossRef302
Botto, Lorenzo D., Moore, Cynthia A., Khoury, Muin J., Erickson, J. David, . (1999) Neural-Tube Defects. New England Journal of Medicine 341:20, 1509-1519
Full Text303
(1999) Folate and Cancer Prevention: A New Medical Application of Folate Beyond Hyperhomocysteinemia and Neural Tube Defects. Nutrition Reviews 57:10, 314-321
CrossRef304
(1999) Folic Acid Fortification. New England Journal of Medicine 341:12, 922-924
Full Text
- Letters
